Neulasta

What to Expect From Amgen, Inc. in 2018
Motley Fool
Sun, 01/21/18 - 10:40 am
Amgen
Enbrel
Neulasta
Aranesp
Epogen
Neupogen
Prolia
Repatha
CAR-T
Will 2018 Be Amgen Inc.'s Best Year Yet?
Motley Fool
Wed, 01/17/18 - 10:08 am
Amgen
Enbrel
Aranesp
Neulasta
Epogen
The 2018 biosimilar litigation landscape: A primer
BioPharma Dive
Sun, 12/17/17 - 11:35 am
biosimilars
FDA
Neupogen
Neulasta
Remicade
Epogen
Enbreal
Humira
Avastin
Herceptin
Novartis seeks to revive Neulasta biosim prospects with data showing it matches Amgen’s blockbuster
Fierce Pharma
Fri, 12/8/17 - 10:41 am
Novartis
Neulasta
biosimilars
Amgen
Sandoz
FDA
Nektar (NKTR) Stock Up More than 300% This Year: Here's Why
Yahoo/Zacks.com
Sat, 11/25/17 - 12:29 pm
Nektar
AstraZeneca
Movantik
Onzeald
UCB Pharma
Cimzia
Amgen
Neulasta
Mylan and Biocon biosimilar of Amgen’s Neulasta hit with manufacturing-related CRL
Fierce Pharma
Tue, 10/10/17 - 10:18 am
Mylan Labs
Biocon
Amgen
Neulasta
CRL
FDA
biosimilars
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan
Coherus cuts staff after FDA red light
BioPharma Dive
Wed, 06/28/17 - 10:52 pm
Coherus Biosciences
layoffs
FDA
biosimilars
Amgen
Neulasta
Amgen loses its bid to delay biosimilars as SCOTUS hands Novartis a victory
Endpoints
Mon, 06/12/17 - 09:24 pm
Amgen
Novartis
Supreme Court
biosimilars
Neulasta
FDA
Coherus Biosciences
Amgen accuses would-be copycat Coherus of stealing its Neulasta secrets
Fierce Pharma
Tue, 03/7/17 - 11:52 am
Coherus Biosciences
Amgen
Neulasta
biosimilars
Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round
Endpoints
Sun, 01/29/17 - 11:53 am
Novartis
biosimilars
Zioxtenzo
Europe
Amgen
Neulasta
China
Amgen Products Threatened by Court Losses
Investopedia
Mon, 09/19/16 - 03:45 pm
Amgen
Apobiologix
Neupogen
Grastofil
Neulasta
Lapelga
biosimilars
patents
U.S. FDA knocks back Novartis copy of Amgen's drug Neulasta
Yahoo/Reuters
Tue, 07/19/16 - 10:18 am
FDA
Novartis
biosimilars
Amgen
Neulasta
EU agency accepts Sandoz application for pegfilgrastim biosimilar
Yahoo/Reuters
Thu, 02/11/16 - 09:16 am
Europe
Sandoz
Novartis
biosimilars
pegfilgrastim
Neulasta
Amgen stalls Apotex's Neulasta biosim launch with court victory
Fierce Pharma
Thu, 12/10/15 - 06:44 pm
Amgen
Apotex
Neulasta
biosimilars
Novartis: Study shows copycat works just as well as Amgen drug
Yahoo/Reuters
Mon, 12/7/15 - 12:10 pm
Novartis
Amgen
Neulasta
Sandoz
generics
breast cancer
Novartis biosimilar takes aim at Amgen drug Neulasta
Yahoo/Reuters
Wed, 11/18/15 - 09:30 am
Novartis
Amgen
biosimilars
Neulasta
Sandoz
Amgen: Time is on My Side
Barron's
Sat, 09/5/15 - 10:56 am
Amgen
Coherus Biosciences
FDA
Neulasta
Apotex
You’re Better Than My Last Dance Partner But Still Not Perfect: Amgen Alleges that an Otherwise Complete Patent Dance Was Ruined by Pre-Approval Notice of Marketing
FDA Law Blog
Mon, 08/17/15 - 08:13 am
FDA
Amgen
Neulasta
Apotex
biogenerics
patents
Amgen: What If Generic Neulasta Gets Delayed Until Next Year?
Barron's
Wed, 08/12/15 - 12:49 pm
Neulasta
generics
Amgen
Apex Labs
biosimilars

Pages